Jefferies Financial Group’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.38M	Buy	666,800 +344,200	+107%	+$712K	0.01%	445
2025 Q1	$710K	Buy	+322,600	New	+$710K	0.01%	748
2023 Q3	–	Sell	-1,290,924	Closed	-$1.5M	–	1254
2023 Q2	$1.5M	Buy	+1,290,924	New	+$1.5M	0.01%	466